Assisted Living Federation of America launches Stop Alzheimer's Petition

Today the Assisted Living Federation of America (ALFA) has launched the Stop Alzheimer's Petition, which urges the President of the United States and members of Congress to make preventing and effectively treating Alzheimer's disease and other forms of dementia a priority on Capitol Hill. Senior living professionals, senior living residents, and other concerned citizens can sign the petition on Facebook and through the ALFA website.    

ALFA has joined with 45 other organizations to ask the public to support the Stop Alzheimer's Petition. Each organization belongs to Leaders Engaged on Alzheimer's Disease (LEAD), a coalition committed to national policies targeted at preventing, treating, and eventually curing Alzheimer's disease. The coalition aims to recruit one million individuals to sign the petition by the end of the year.

The petition asks the President and Congress to fully fund and support the National Plan to Address Alzheimer's Disease, which was developed earlier this year as part of the National Alzheimer's Project Act. Alzheimer's is the sixth leading cause of death in America. No effective prevention, disease modifying treatment, or cure is currently available.

"Millions of individuals, including 42 percent of assisted living residents according to the National Survey of Residential Care Facilities, are affected by the devastating nature of Alzheimer's disease and related dementias," said ALFA President & CEO Richard P. Grimes. "Improving quality of life for these individuals and their families has long been a priority of ALFA and should be a priority of our elected officials. Through the Stop Alzheimer's Petition, those touched by this debilitating disease can make their voices heard and help ensure a brighter future for those with Alzheimer's disease or related dementia."

Source:

Assisted Living Federation of America        

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Flaws in study design may limit detection of cognitive effects in diet trials